The United Kingdom has on Wednesday approved the emergency use of Pfizer-BioNTech vaccine use becoming the first country in the world to do so.
The news will see the company begin deliveries from next week in phases until the next year 2021 as confirmed by the company itself.
“The MHRAgovuk issued a temporary authorization for emergency use of our COVID19 vaccine with BioNTech_Group in the United Kingdom. This marks the first authorization of a vaccine to help fight the pandemic following a worldwide trial.” said Pfizer.
- Kenya’s COVID-19 fatalities rise by 5 to 1,474
- Eritrea capital hit by rockets as Ethiopia declare victory
- London police arrest over 150 anti-lockdown protesters
- Mohsen Fakhrizadeh: Iran nuclear scientist killed in Tehran
Pfizer further noted that authorization was temporary with further regulatory processes across the world expected next week as they get ready to make deliveries once confirmed.
“Today’s Emergency Use Authorization in the U.K. marks a historic moment in the fight against COVID-19. This authorization is a goal we have been working toward since we first declared that science will win, and we applaud the MHRA for their ability to conduct a careful assessment and take timely action to help protect the people of the U.K.
As we anticipate further authorizations and approvals, we are focused on moving with the same level of urgency to safely supply a high-quality vaccine around the world. With thousands of people becoming infected, every day matters in the collective race to end this devastating pandemic.” said Pfizer CEO Albert Bouria.
The news comes at time when African countries are contemplating on how soon they will have the vaccine as WHO warns of delays given logistics and financial strains in the continent.